A case of primary breast angiosarcoma with multiple discontinuous small lesions.

Angiosarcoma Breast Multifocal tumor Surgery

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
25 Oct 2019
Historique:
received: 15 05 2019
accepted: 11 09 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 28 10 2019
Statut: epublish

Résumé

Angiosarcoma of the breast is rare. It carries a poor prognosis because of its high risk of local recurrence and distant metastases. Presently, there are still no established systemic therapies. Thus, the main treatment strategy for breast angiosarcoma is complete resection. This underscores the importance of closely monitoring the spread of the tumor lesion, particularly for multifocal angiosarcoma, and to plan an optimal operative procedure. We herein present the successful surgical treatment of a rare case of multifocal primary breast angiosarcoma. A 43-year-old woman visited our hospital with a growing lump on her right breast accompanied by pain. Clinical and radiological examinations revealed a well-circumscribed 40-mm-diameter tumor at the inner lower quadrant of her right breast. Histological examination of a needle biopsy specimen revealed angiosarcoma. Based on a precise evaluation of the tumor by contrast-enhanced MRI and contrast-enhanced CT scan, a wide local excision with sufficient margins was performed. In the resected specimen, three discontinuous small lesions of angiosarcoma were observed around the main tumor. Therefore, total mastectomy was additionally performed. Pathological examination revealed two other small nodules of angiosarcoma in the remnant right breast, which appeared to be close but not continuous to the defective part of the initial resection. Postoperative follow-up at 1 year showed no signs of recurrence or distant metastasis. Multifocal primary breast angiosarcoma is extremely rare with only two previous reports describing its multifocality. Owing to its rarity, a standardized surgical treatment for breast angiosarcoma remains controversial. Our case suggests that primary breast angiosarcoma may occasionally present with multifocal tumor. Thus, it is important to keep in mind the multifocality of breast angiosarcoma when assessing its spread by diagnostic imaging and when planning the surgical strategy.

Sections du résumé

BACKGROUND BACKGROUND
Angiosarcoma of the breast is rare. It carries a poor prognosis because of its high risk of local recurrence and distant metastases. Presently, there are still no established systemic therapies. Thus, the main treatment strategy for breast angiosarcoma is complete resection. This underscores the importance of closely monitoring the spread of the tumor lesion, particularly for multifocal angiosarcoma, and to plan an optimal operative procedure. We herein present the successful surgical treatment of a rare case of multifocal primary breast angiosarcoma.
CASE PRESENTATION METHODS
A 43-year-old woman visited our hospital with a growing lump on her right breast accompanied by pain. Clinical and radiological examinations revealed a well-circumscribed 40-mm-diameter tumor at the inner lower quadrant of her right breast. Histological examination of a needle biopsy specimen revealed angiosarcoma. Based on a precise evaluation of the tumor by contrast-enhanced MRI and contrast-enhanced CT scan, a wide local excision with sufficient margins was performed. In the resected specimen, three discontinuous small lesions of angiosarcoma were observed around the main tumor. Therefore, total mastectomy was additionally performed. Pathological examination revealed two other small nodules of angiosarcoma in the remnant right breast, which appeared to be close but not continuous to the defective part of the initial resection. Postoperative follow-up at 1 year showed no signs of recurrence or distant metastasis. Multifocal primary breast angiosarcoma is extremely rare with only two previous reports describing its multifocality.
CONCLUSIONS CONCLUSIONS
Owing to its rarity, a standardized surgical treatment for breast angiosarcoma remains controversial. Our case suggests that primary breast angiosarcoma may occasionally present with multifocal tumor. Thus, it is important to keep in mind the multifocality of breast angiosarcoma when assessing its spread by diagnostic imaging and when planning the surgical strategy.

Identifiants

pubmed: 31654286
doi: 10.1186/s40792-019-0704-8
pii: 10.1186/s40792-019-0704-8
pmc: PMC6814660
doi:

Types de publication

Journal Article

Langues

eng

Pagination

157

Références

J Clin Oncol. 2003 Jul 1;21(13):2583-8
pubmed: 12829679
Ann Surg Oncol. 2013 Apr;20(4):1267-74
pubmed: 23224828
Pathol Int. 2015 Oct;65(10):554-7
pubmed: 26272464
Radiother Oncol. 2007 Dec;85(3):355-61
pubmed: 18023492
Breast Cancer. 2016 Sep;23(5):718-23
pubmed: 26243043
World J Oncol. 2014 Jun;5(3):144-148
pubmed: 29147394
Am J Clin Oncol. 2007 Dec;30(6):570-3
pubmed: 18091049
Lancet Oncol. 2010 Oct;11(10):983-91
pubmed: 20537949
Gland Surg. 2014 Feb;3(1):28-34
pubmed: 25083491
Curr Oncol. 2018 Feb;25(1):e50-e53
pubmed: 29507495
Semin Diagn Pathol. 1987 Feb;4(1):2-17
pubmed: 3313596
Intern Med. 2015;54(22):2867-72
pubmed: 26568000
J Exp Clin Cancer Res. 2015 Jul 30;34:72
pubmed: 26219853
Br J Cancer. 2004 Jul 19;91(2):237-41
pubmed: 15187996
Int J Surg Case Rep. 2015;10:169-72
pubmed: 25853844

Auteurs

Asako Sasahara (A)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. tsujiyama-tho@umin.ac.jp.

Masahiko Tanabe (M)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kanako Hayashi (K)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Takaaki Konishi (T)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Mariko Oya (M)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kana Sakiyama (K)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Arisa Morizono (A)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Mayumi Harada (M)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kazutaka Otsuji (K)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yuko Ishibashi (Y)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Ayaka Sato (A)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yasuko Kikuchi (Y)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Takayoshi Niwa (T)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Munetoshi Hinata (M)

Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan.

Kotoe Nishioka (K)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yasuyuki Seto (Y)

Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Classifications MeSH